about
Human Mesenchymal Stromal Cells from Different Sources Diverge in Their Expression of Cell Surface Proteins and Display Distinct Differentiation PatternsPotential capacity of aptamers to trigger immune activation in human blood.In vitro test system for evaluation of immune activation potential of new single-stranded DNA-based therapeutics.Microfluidic chip system for the selection and enrichment of cell binding aptamersIn vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials.Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies.Rapid Complexation of Aptamers by Their Specific Antidotes.Importance of rigorous in vitro evaluation of prospective cell binding aptamers.Absolute quantification of cell-bound DNA aptamers during SELEX.Pitfalls of cell-systematic evolution of ligands by exponential enrichment (SELEX): existing dead cells during in vitro selection anticipate the enrichment of specific aptamers.Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression.Speeding up pyrogenicity testing: Identification of suitable cell components and readout parameters for an accelerated monocyte activation test (MAT).Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges.New basic approach to treat non-small cell lung cancer based on RNA-interference.Development of hydrogels for regenerative engineering.In vivo tissue engineering: mimicry of homing factors for self-endothelialization of blood-contacting materials.Streptavidin-coated magnetic beads for DNA strand separation implicate a multitude of problems during cell-SELEX.In Vitro Evaluation of a Novel mRNA-Based Therapeutic Strategy for the Treatment of Patients Suffering from Alpha-1-Antitrypsin Deficiency.Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications.Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing.Use of synthetic single-stranded oligonucleotides as artificial test soiling for validation of surgical instrument cleaning processes.RNA-Eluting Surfaces for the Modulation of Gene Expression as A Novel Stent Concept.In vitro synthesis of modified mRNA for induction of protein expression in human cells.Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation.Generation of Large-Scale DNA Hydrogels with Excellent Blood and Cell Compatibility.Selection and Application of Aptamers and Intramers.Hemocompatibility of Axial Versus Centrifugal Pump Technology in Mechanical Circulatory Support Devices.One-staged aptamer-based isolation and application of endothelial progenitor cells in a porcine myocardial infarction model.Preclinical evaluation of the thrombogenicity and endothelialization of bare metal and surface-coated neurovascular stents.Incorporation of Synthetic mRNA in Injectable Chitosan-Alginate Hybrid Hydrogels for Local and Sustained Expression of Exogenous Proteins in Cells.De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells.Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAsAptamers Influence the Hemostatic System by Activating the Intrinsic Coagulation Pathway in an In Vitro Chandler-Loop ModelExogenous Delivery of Link N mRNA into Chondrocytes and MSCs-The Potential Role in Increasing Anabolic ResponseGeneration of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNABlood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility.Current concepts and new developments for autologous in vivo endothelialisation of biomaterials for intravascular applicationsPorcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivation
P50
Q26771921-47A4730C-A5E3-4EA0-AF65-2BDEE550639FQ34918601-20D072D4-B2B3-461F-9962-108B685335DCQ35166708-A7702CAA-0FD1-40A1-86B6-89DB8B2725AAQ35693283-F9C473CF-391A-4A4E-87EA-C78D52C91812Q35779631-D3A821B6-A180-4059-B0EE-3B2355D90B6FQ37221813-7512F262-24D9-460E-837C-196D4CD80AFBQ37625141-86C7687F-4AC1-4B51-ADA6-657A1DFAF802Q38287977-F236895A-753E-44AF-8B87-7C55F8D20CFDQ38305566-4D2BAB97-1353-4F15-87B9-B8CB237166B7Q38317729-FD6008E2-2C54-499C-AF74-723DF22A9865Q38338889-0306DAE0-B952-4736-956B-F74DF9D8B9D3Q38617089-CC1C14E4-D3C7-46FB-9CC7-3659402C5B78Q38774919-F3862705-E4E8-44C5-A52E-799592BBF549Q38850538-EB006C6D-966C-4DBE-A07E-3B119789543BQ39020392-948034F4-66A4-4E94-8D23-553C8233DA4EQ39145111-A1372877-79FD-4252-A1A6-F6EF942DF12EQ39423192-98D1A92C-DE53-43F9-A77C-B858D95CB156Q39803485-367F5166-A1D5-455E-A0CD-DC5A61F7D736Q40782137-09E0E020-EFE2-4946-BD79-45EAA34CEEBEQ41271806-628B8AE5-BEB0-4A46-9590-5A58619C9962Q41809791-22A1FFD5-6B1B-4D07-8C5E-E8BB937A84AAQ41967764-FDAFA19F-D828-480D-9AC8-5B2A47FB224AQ42143396-569CCCA4-6EC0-4459-8504-31B9A611636DQ43181174-904ABEEA-AA4B-480E-B9AA-3430CD615852Q43499106-F403C98A-84E4-415E-A9A9-2EFAC51B6F2AQ51132858-2A59E122-E8AC-4C2D-9C83-5630E8786252Q51313422-BAF3CC26-A79C-49A3-8A56-3C810690795EQ51824731-815D741C-E755-48EF-9611-FE48A7643953Q52994024-9F1E999C-D34C-4855-A93E-548D2A4BDFE9Q53433253-B7835CDD-31A2-490C-B2AD-D833EB8F4FDCQ55017511-A51A18A1-5367-4E42-88D5-4F47571A3118Q55023090-DA626CAF-8A60-498A-8AC4-B2045CCC7FB5Q55135924-CD17F359-41AA-4BE4-9C92-11AD495D8ED3Q57822301-5332DBFA-8E4E-403C-842E-70800D00272BQ60028606-DAF26DE0-4D50-49A5-9567-F424AF39E816Q64069601-43E20545-F44A-4B5F-809F-F9CBBA068944Q64080348-C13A64F1-EF0B-4B46-BD01-0693BE245859Q64957766-41621467-0D6F-43A0-8BDF-B6EEC0B4792DQ83396399-FEDD95BE-CB35-496A-A392-3BE8D506E780Q84165051-23FAA996-0636-42C3-B105-DE2B0D13DC6E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Meltem Avci-Adali
@en
Meltem Avci-Adali
@nl
type
label
Meltem Avci-Adali
@en
Meltem Avci-Adali
@nl
prefLabel
Meltem Avci-Adali
@en
Meltem Avci-Adali
@nl
P31
P496
0000-0003-4008-4272